These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32901297)

  • 21. Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy.
    Tsilou ET; Rubin BI; Reed G; Caruso RC; Iwata F; Balog J; Gahl WA; Kaiser-Kupfer MI
    Ophthalmology; 2006 Jun; 113(6):1002-9. PubMed ID: 16603246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and neurophysiological characterization of early neuromuscular involvement in children and adolescents with nephropathic cystinosis.
    Elkhateeb N; Selim R; Soliman NA; Atia FM; Abouelwoun II; Elmonem MA; Helmy R
    Pediatr Nephrol; 2022 Jul; 37(7):1555-1566. PubMed ID: 34791528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of topical cysteamine in nephropathic cystinosis.
    Al-Hemidan A; Shoughy SS; Kozak I; Tabbara KF
    Br J Ophthalmol; 2017 Sep; 101(9):1234-1237. PubMed ID: 28057644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis.
    Emma F; Hoff WV; Hohenfellner K; Topaloglu R; Greco M; Ariceta G; Bettini C; Bockenhauer D; Veys K; Pape L; Hulton S; Collin S; Ozaltin F; Servais A; Deschênes G; Novo R; Bertholet-Thomas A; Oh J; Cornelissen E; Janssen M; Haffner D; Ravà L; Antignac C; Devuyst O; Niaudet P; Levtchenko E
    Kidney Int; 2021 Nov; 100(5):1112-1123. PubMed ID: 34237326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up.
    Dohil R; Cabrera BL
    Pediatr Nephrol; 2013 Mar; 28(3):507-10. PubMed ID: 23001048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body growth, upper arm fat area, and clinical parameters in children with nephropathic cystinosis compared with other pediatric chronic kidney disease entities.
    Kluck R; Müller S; Jagodzinski C; Hohenfellner K; Büscher A; Kemper MJ; Oh J; Billing H; Thumfart J; Weber LT; Acham-Roschitz B; Arbeiter K; Tönshoff B; Hagenberg M; Kanzelmeyer N; Pavičić L; Haffner D; Zivicnjak M
    J Inherit Metab Dis; 2022 Mar; 45(2):192-202. PubMed ID: 34989402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy.
    Sonies BC; Almajid P; Kleta R; Bernardini I; Gahl WA
    Medicine (Baltimore); 2005 May; 84(3):137-146. PubMed ID: 15879904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment of infantile nephropathic cystinosis with cysteamine.
    da Silva VA; Zurbrügg RP; Lavanchy P; Blumberg A; Suter H; Wyss SR; Lüthy CM; Oetliker OH
    N Engl J Med; 1985 Dec; 313(23):1460-3. PubMed ID: 4058549
    [No Abstract]   [Full Text] [Related]  

  • 29. Nephropathic cystinosis: effect of long-term cysteamine therapy.
    Proesmans W; Baten E; Hoogmartens J; Bruyneel P
    Clin Nephrol; 1987 Jun; 27(6):309-12. PubMed ID: 3608256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NIH conference. Cystinosis: progress in a prototypic disease.
    Gahl WA; Thoene JG; Schneider JA; O'Regan S; Kaiser-Kupfer MI; Kuwabara T
    Ann Intern Med; 1988 Oct; 109(7):557-69. PubMed ID: 3048161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome.
    Levtchenko EN; de Graaf-Hess A; Blom HJ; Monnens LA
    Clin Nephrol; 2002 May; 57(5):349-51. PubMed ID: 12036193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic Cystinosis.
    Wühl E; Haffner D; Gretz N; Offner G; van't Hoff WG; Broyer M; Mehls O
    Pediatr Res; 1998 Apr; 43(4 Pt 1):484-8. PubMed ID: 9545002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central nervous system complications in adult cystinosis patients.
    Servais A; Saitovitch A; Hummel A; Boisgontier J; Scemla A; Sberro-Soussan R; Snanoudj R; Lemaitre H; Legendre C; Pontoizeau C; Antignac C; Anglicheau D; Funalot B; Boddaert N
    J Inherit Metab Dis; 2020 Mar; 43(2):348-356. PubMed ID: 31444911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenchymal organ cystine depletion with long-term cysteamine therapy.
    Gahl WA; Charnas L; Markello TC; Bernardini I; Ishak KG; Dalakas MC
    Biochem Med Metab Biol; 1992 Dec; 48(3):275-85. PubMed ID: 1476793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse reactions to oral cysteamine use in nephropathic cystinosis.
    Corden BJ; Schulman JD; Schneider JA; Thoene JG
    Dev Pharmacol Ther; 1981; 3(1):25-30. PubMed ID: 7307866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report.
    Higashi S; Matsunoshita N; Otani M; Tokuhiro E; Nozu K; Ito S
    BMC Nephrol; 2017 Sep; 18(1):300. PubMed ID: 28950840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cysteamine therapy for children with nephropathic cystinosis.
    Gahl WA; Reed GF; Thoene JG; Schulman JD; Rizzo WB; Jonas AJ; Denman DW; Schlesselman JJ; Corden BJ; Schneider JA
    N Engl J Med; 1987 Apr; 316(16):971-7. PubMed ID: 3550461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Report of a Brazilian multicenter study on nephropathic cystinosis.
    Vaisbich MH; Koch VH
    Nephron Clin Pract; 2010; 114(1):c12-8. PubMed ID: 19816039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steady-state pharmacokinetics and pharmacodynamics of cysteamine bitartrate in paediatric nephropathic cystinosis patients.
    Belldina EB; Huang MY; Schneider JA; Brundage RC; Tracy TS
    Br J Clin Pharmacol; 2003 Nov; 56(5):520-5. PubMed ID: 14651726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up and treatment of adults with cystinosis in the Netherlands.
    Geelen JM; Monnens LA; Levtchenko EN
    Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.